MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

HRTX — Heron Therapeutics, Inc.

Nasdaq

Heron Therapeutics, Inc.

CompareBack to Screener
$0.35
-0.01(-2.33%)
O
0.36
H
0.41
L
0.34
V
4.06M
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Chart

About HRTX

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateAug 27, 1987
Employees128
Stock ExchangeNasdaq
Ticker SymbolHRTX
Websitehttps://www.herontx.com

Key Financial Statistics

Market Cap$65.99M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$0.26 - $1.58
52-Week Avg Volume2.37M
VWAP$0.37
Transactions10,806
Total Recorded Bars9,849 days